Janssen Research & Development, Llc

This study tested whether adding daratumumab to the standard drugs lenalidomide and dexamethasone helps people with newly diagnosed multiple myeloma live longer without their cancer getting worse. The trial included 737 adults who were not healthy enough for high-dose chemotherap…

This study tested whether adding a new drug (nipocalimab) to an existing one (certolizumab) works better than certolizumab alone for people with active rheumatoid arthritis. About 103 adults who had not improved with prior advanced treatments took part. The goal was to see if the…

This study tested whether an experimental drug called nipocalimab could reduce disease activity and symptoms in adults with primary Sjogren's syndrome, an autoimmune condition that causes severe dryness, fatigue, and pain. Researchers compared nipocalimab against a placebo in 163…